Comron Hassanzadeh, MD, MPH
Department of GU Radiation Oncology, Division of Radiation Oncology
About Dr. Comron Hassanzadeh
Comron Hassanzadeh, MD, MPH, is an Assistant Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. Dr. Hassanzadeh is the Associate Medical Director of The Proton Therapy Center and Co-Director of The Bone Metastasis Clinic. Dr. Hassanzadeh specializes in the management of patients with prostate, bladder, kidney, testicular, and patients with bone metastases. Prior to his appointment, he earned his medical degree from the University of Missouri Kansas City. He then completed a residency in Radiation Oncology at Washington University School of Medicine. During residency, he completed a Master of Public Health at the University of Missouri.
Dr. Hassanzadeh has clinical expertise in a variety of radiation modalities including intensity modulated radiation (IMRT), proton therapy, stereotactic body radiation therapy (SBRT), brachytherapy, magnetic resonance guided radiation, and online adaptive radiation. He serves as the Principal Investigator on both prostate and bladder cancer trials aiming to define clinical practice. He has received extramural research support and his research has been presented at national/international conferences and published in high-impact, peer-reviewed journals. In addition, he has authored national guidelines for the management of prostate and bladder cancer through committee service in the American Radium Society, American Society for Therapeutic Radiation Oncology, and International Bladder Cancer Group.
He currently serves in various leadership roles within organizations including NRG Oncology, American College of Radiation Oncology, American Society for Therapeutic Radiation Oncology, ECOG-ACRIN, International Bladder Cancer Group, Bladder Cancer Advocacy Network, Radiological Society of North America, American Radium Society, and American College of Radiology.
Present Title & Affiliation
Primary Appointment
Associate Medical Director, Department of Proton Therapy Center, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Residency Associate Program Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Co-Director, Department of Bone Metastasis Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2019 | University of Missouri Columbia, Columbia, Missouri, US, Master of Public Health (MPH) |
| 2017 | University of Missouri Kansas City, Kansas City, Missouri, US, MD |
| 2013 | Saint Louis University, St. Louis, Missouri, US, Medical Science, BS |
Postgraduate Training
| 2018-2022 | Clinical Residency, Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri |
| 2017-2018 | Clinical Residency, Transitional Medicine, Mercy Hospital St. Louis, St. Louis, Missouri |
Licenses & Certifications
| 2025 | Acute Cardiovascular Life Support (ACLS) |
| 2023 | Basic Life Support (BLS) |
| 2023 | American Board of Radiology (ABR), Radiation Oncology |
| 2022 | Texas Medical Board |
| 2022 | American Board of Radiology, Clinical Qualifying Exam |
| 2021 | American Board of Radiology, Biology Qualifying Exam |
| 2021 | American Board of Radiology, Physics Qualifying Exam |
| 2018 | United States Medical Licensing Exam (USMLE) Step 2 CS |
| 2017 | United States Medical Licensing Exam (USMLE) Step 2 CK |
| 2016 | United States Medical Licensing Exam (USMLE) Step 1 |
Experience & Service
Faculty Academic Appointments
Chief Resident, Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, 2021 - 2022
Assistant Chief Resident, Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, 2020 - 2021
Administrative Appointments/Responsibilities
Associate Medical Director, Department of Proton Therapy Center, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Bone Metastasis Clinic Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Residency Program Associate Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Genitourinary Medical Student Site Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Bone Metastasis Clinic Genitourinary Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Bladder Working Group, Radiation Oncology Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Genitourinary Residency Education Site Director, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Other Professional Positions
Genitourinary Abstract Review Committee, American Society of Therapeutic Radiation Oncology (ASTRO), 2025 - Present
New Practitioner Committee Chair, American College of Radiation Oncology, 2025 - Present
Education Committee: Palliative Track, American Society of Therapeutic Radiation Oncology (ASTRO), 2024 - Present
Theranostics Subcommittee, NRG Oncology, 2024 - Present
Member at Large, Texas Radiological Society, Texas, 2024 - Present
New Practitioner Committee, Vice Chair, American College of Radiation Oncology, 2024 - Present
Abstract Review Committee, American College of Radiation Oncology, 2023 - Present
Patient Centered Outcomes Research Committee, NRG Oncology, Houston, TX, 2023 - Present
Core Committee Member, International Bladder Cancer Group (IBCG), Houston, TX, 2023 - Present
Developmental Therapeutics RT Subcommittee Member, NRG Oncology, Houston, TX, 2022 - Present
Genitourinary Cancer Committee Member, NRG Oncology, Houston, TX, 2022 - Present
Genitourinary Cancer Committee, Bladder Working Group Member, NRG Oncology, Houston, TX, 2022 - Present
Finance & Development Committee Member, American College of Radiation Oncology (ACRO), Houston, TX, 2022 - Present
Membership Committee Member, American College of Radiation Oncology (ACRO), Houston, TX, 2021 - Present
Treasurer and Radiation Oncology Representative, Missouri Radiological Society, St. Louis, MO, 2021 - 2022
Abstract Review Committee Member, American College of Radiation Oncology (ACRO), Houston, TX, 2021 - Present
New Investigators Committee Member, NRG Oncology, Houston, TX, 2021 - Present
Radiology Leadership Institute Member, American Board of Radiology, St. Louis, MO, 2021 - Present
Medical School Tutor, MedSchoolCoach, National, 2020 - 2022
Fellow, PrecisCa Consulting, Boca Raton, FL, 2020 - 2022
Resident Committee Chair, American College of Radiation Oncology (ACRO), St. Louis, MO, 2020 - 2021
Scientific Program Committee, Resident Chair, American College of Radiation Oncology (ACRO), N/A, 2020 - 2021
Resident Scholarship Chair, American College of Radiation Oncology (ACRO), St. Louis, MO, 2019 - 2020
AOA Chapter President, University of Missouri Kansas City, Kansas City, MO, 2016 - 2017
Main Operations Manager, University of Missouri, Sojourner Free Health Clinic, Kansas City, MO, 2016 - 2017
Council on Curriculum Student Chair, University of Missouri Kansas City, Kansas City, MO, 2014 - 2015
Institutional Committee Activities
Team Lead, Adaptive Billing Working Group, 2025 - Present
Member, Genitourinary Radiation Oncology Department Chair Search Advisory Committee, 2024 - Present
Panel Member, Radiation Oncology Fellowship Interview Panel Committee, 2024 - Present
Lead, Radiation Oncology Residency Program - Theranostics Pathway Lead, 2024 - Present
Radiation Oncology Lead, Bladder Cancer Algorithm Committee, 2024 - Present
Associate Program Director, Radiation Oncology Residency Interview Committee, 2024 - Present
Bone Metastasis Lead, Theranostics Working Group, 2024 - Present
GU Representative, Radiation Oncology Faculty Search Committee, 2024 - Present
Member, Radiation Oncology Remote Simulation Committee, 2023 - Present
Panel Member, Radiation Oncology Residency Interview Committee, 2023 - Present
Member, Graduate Medical Education Committee, 2023 - Present
Member, FLASH Working Group, 2023 - Present
Member, Radiation Oncology HDR Brachytherapy Pilot Program Group, 2023 - Present
Genitourinary Lead, Radiation Oncology Residency Clinical Competency Committee, 2023 - Present
Member, MD Anderson Bladder Working Group, 2022 - Present
Honors & Awards
| 2025 - Present | John Quale Travel Fellowship Award, Bladder Cancer Advocacy Network (BCAN) |
| 2025 - Present | Selected as Associate Medical Director of The Proton Center, The University of Texas MD Anderson Cancer Center |
| 2025 - Present | Selected as New Practitioner Commitee Chair, American College of Radiation Oncology |
| 2024 | Elected as Member at Large, Texas Radiological Society |
| 2024 | American College of Radiation Oncology Mentorship Award, American College of Radiation Oncology (ACRO) |
| 2024 | Selected as Bone Metastasis Clinic Director, MD Anderson Cancer Center |
| 2024 | ASTRO Annual Meeting Abstract Award, American Society for Radiation Oncology |
| 2024 | Top Performer - Top 1% CAHPS Survey Performance, MD Anderson Physician Referral Service |
| 2023 | Machtay Young Investigator Travel Award, NRG Oncology |
| 2023 | National Top Provider, National Patient Experience Survey, CAHPS, MD Anderson Cancer Center |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Bladder Cancer, Trimodal Therapy, and The Future of Radiation. Visiting. St. Louis, Missouri, US.
- 2023. ASTRO GU Highlights 2023. Houston, Texas, US.
- 2023. Trimodality Bladder Cancer. Mel Klein Bladder Cancer Lectureship Series. Houston, Texas, US.
- 2023. Bladder Cancer Management Series. Houston, Texas, US.
Regional Presentations
- 2025. Bone Metastasis: Oncologic Management. Invited. Invited Speaker: Radiation Oncology and Orthopedic Oncology Society, US.
National Presentations
- 2025. Trimodality Therapy: Bladder Preserving Strategies and Liquid Biopsies. Invited. Bladder Cancer Advocacy Network (BCAN) Think Tank, US.
- 2025. The Evolution of Radiation for Bladder Cancer. Invited. Christopher G Wood Advances in Urologic Oncology Symposium. Austin, TX, US.
- 2025. EV/IO and the Evolution of Radiation for Bladder Cancer. Invited. Bladder Cancer Advocacy Network (BCAN) Think Tank, US.
- 2025. Rediscovering Radiation Medicine and Exploring New Indications. Invited. ASTRO 2025. San Francisco, CA, US.
- 2024. Trimodality Therapy and Bladder Preservation: Bladder Cancer. Invited. Radiation Oncology Virtual Lecture Series, US.
- 2024. MD Anderson Hypofractionated Intensity Modulated Radiation for Prostate Cancer Trial: 15 Year Update. Conference. ASTRO 2024. Washington, DC, US.
- 2024. Trimodality Therapy for Bladder Cancer and Organ Preservation. Invited. Invited Speaker- RUSH MD Anderson Cancer Center Radiation Oncology Residency Virtual Seminar Series. Chicago, Illinois, US.
- 2024. Muscle Invasive Bladder Cancer and Node Positive Bladder Cancer: Trimodality Therapy. Invited. Network Radiation Oncology (NERO) 2024, US.
- 2024. Seminoma Management: Panelist. Conference. Christopher G Wood Advances in Urologic Oncology Symposium 2024. Austin, TX, US.
- 2024. Muscle Invasive Bladder Cancer: Radiation Oncology Challenging Cases. Conference. Mel Klein Lectureship in Bladder Cancer, US.
- 2024. Trimodality Therapy for Bladder Cancer and Organ Preservation. Invited. Invited Speaker-The University of Texas San Antonio Radiation Oncology Residency Virtual Visiting Lecturship Series, US.
- 2024. Personalizing Prostate Cancer Care with a Prognostic Biomarker. Invited. American College of Radiation Oncology Podcast Series, US.
- 2023. Meet the Experts: MD Anderson Cancer Center, ASTRO Annual Meeting 2023. Invited, US.
- 2023. Bladder Preserving Strategies: Radiation Oncology Perspective. Conference. Bladder Preserving Strategies: Radiation Oncology Perspective. Austin, TX, US.
- 2023. Trimodality Therapy for Bladder Cancer. Invited. International Bladder Cancer Group Annual Meeting, US.
- 2023. Updates on Bladder Cancer Trimodal Therapy and Bladder Preservation. Conference. Mel Klein Lectureship in Bladder Cancer, US.
- 2020. Navigating the Radiation Oncology 2021 Match. Conference. Navigating the Radiation Oncology 2021 Match, US.
- 2020. Early MRI Changes of Glioblastoma During Chemoradiotherapy and Implications for Treatment Planning. Conference. Early MRI Changes of Glioblastoma During Chemoradiotherapy and Implications for Treatment Planning, US.
- 2020. Head and Neck Quad Shot Using CT Based Adaptive Treatment on a Ring Gantry LINAC. Conference. Head and Neck Quad Shot Using CT Based Adaptive Treatment on a Ring Gantry LINAC, US.
- 2020. Amiodarone Use and Radiation Pneumonitis in Patients Undergoing Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer. Conference. Amiodarone Use and Radiation Pneumonitis in Patients Undergoing Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer, US.
- 2020. Stereotactic MR-Guided Adaptive Radiation Therapy for Inoperable Pancreatic Cancer Using a 5- Fraction Approach. Conference. Stereotactic MR-Guided Adaptive Radiation Therapy for Inoperable Pancreatic Cancer Using a 5- Fraction Approach, US.
- 2019. Multi-institutional Study of Pneumonitis after Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer. Conference. Multi-institutional Study of Pneumonitis after Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer. Chicago, IL, US.
- 2019. Prognostic significance of p16 in patients with cervical cancer receiving chemoradiation. Conference. Prognostic significance of p16 in patients with cervical cancer receiving chemoradiation. Dana Point, CA, US.
- 2017. Correlation & Prognostic Significance of Pre-Treatment F-FDG- and Cu-ATSM-PET/CT for Cervical Cancer. Conference. Correlation & Prognostic Significance of Pre-Treatment F-FDG- and Cu-ATSM-PET/CT for Cervical Cancer. San Diego, CA, US.
- 2017. A Single Institution Experience with the Utility of Brain Simultaneous 18F-FDG-PET/MRI to Differentiate Tumor Recurrence from Radiation Necrosis. Conference. A Single Institution Experience with the Utility of Brain Simultaneous 18F-FDG-PET/MRI to Differentiate Tumor Recurrence from Radiation Necrosis. Colorado Springs, CO, US.
- 2017. Multiparametric Advanced MR and FDG PET Imaging is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. Conference. Multiparametric Advanced MR and FDG PET Imaging is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. San Diego, CA, US.
- 2017. A Competing Risk Nomogram to Predict Severe Late Toxicity After Modern Re-Irradiation for Squamous Carcinoma of the Head and Neck. Conference. A Competing Risk Nomogram to Predict Severe Late Toxicity After Modern Re-Irradiation for Squamous Carcinoma of the Head and Neck. San Diego, CA, US.
- 2016. Refining Patient Selection for Re-Irradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-Institution Cohort Study by the MIRI Collaborative. Conference. Refining Patient Selection for Re-Irradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-Institution Cohort Study by the MIRI Collaborative. Boston, MA, US.
- 2016. Association of Post- Treatment Positron Emission Tomography Response with Local-regional Control and Survival after Radiation for Vulvar Cancer. Conference. Association of Post- Treatment Positron Emission Tomography Response with Local-regional Control and Survival after Radiation for Vulvar Cancer. Chicago, IL, US.
- 2015. Acid-Sensing Ion Channels Control Locomotor and Rewarding Effects of Amphetamine. Conference. Acid-Sensing Ion Channels Control Locomotor and Rewarding Effects of Amphetamine. Chicago, IL, US.
- 2015. Regulation of Locomotor Activity following Amphetamine Administration by Acid-sensing Ion Channel in Adult Mice. Conference. Regulation of Locomotor Activity following Amphetamine Administration by Acid-sensing Ion Channel in Adult Mice. Washington, DC, US.
- 2011. Adenosinergic Modulation of Spatial Memory and Motor Function in Parkinson’s disease. Conference. Adenosinergic Modulation of Spatial Memory and Motor Function in Parkinson’s disease. Saint Louis, MO, US.
International Presentations
- 2025. Dose-escalated radiation vs conventionally fractionated radiation for prostate cancer. OnlineOnly. VJOncology Journal Club, US.
- 2025. The Role of Metastasis-Directed Radiotherapy in Oligometastatic Urothelial Carcinoma. OnlineOnly. ASCO GU, US.
- 2025. UroToday: EAU 2025 Rapid Fire Debates (Management of positive soft tissue margins after radical cystectomy. What about isolated pelvic recurrences after cystectomy?). OnlineOnly. EAU, US.
- 2025. Bladder Cancer: Common problems and controversies. Invited. European Assocation of Urology 2025. Madrid, ES.
- 2025. Optimizing Prostate Cancer Management: Leveragin PSMA Imaging to Enhance Treatment Strategies. OnlineOnly, US.
Formal Peers
- 2020. Navigating the Radiation Oncology Match. Invited, US.
Grant & Contract Support
| Date: | 2024 - Present |
| Title: | Myriad Industry Grant |
| Funding Source: | Myriad Genetics |
| Role: | PI |
| Date: | 2021 - 2022 |
| Title: | American College of Radiation Oncology (ACRO) Resident Seed Grant |
| Funding Source: | American College of Radiation Oncology (ACRO) |
| Role: | Co-PI |
| Date: | 2019 - 2022 |
| Title: | Varian Medical Systems Research Grant |
| Funding Source: | Varian Medical Systems |
| Role: | Co-PI |
| Date: | 2015 - 2017 |
| Title: | Alpha Omega Alpha (AOA) Carolyn L. Kuckein Student Research Fellowship Grant |
| Funding Source: | Alpha Omega Alpha (AOA) |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Hassanzadeh, CJ, Mohamad, O, Bruno, TL, Wang, L, Kudchakar, R, Bathala, TK, Sanders, JW, Mok, H, McGuire, SE, Kuban, DA, Hoffman, K, Nguyen, Q, Park, RJ, Thames, HD, Corn, P, Chapin, BF, Choi, S, Tang, C, Frank, SJ. Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy 24(2):231-237, 2025. e-Pub 2025. PMID: 39755443.
- Liu W, Schiff JP, Hassanzadeh C, Miller K, Hatscher C, Beckert R, Price A, Daly M, Brenneman R, Henke L, Apicelli A, Moravan M, Thorstad W, Laugeman E. Palliative expeditiously adaptive quad shot radiotherapy for head and neck cancers (PEAQ-RT). Clin Transl Radiat Oncol 54, 2025. e-Pub 2025. PMID: 40703666.
- Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee W, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE. Hypofractionated Radiotherapy for Prostate Cancer (HYDRA): An Individual Patient Data Meta-Analysis of Randomised Trials in MARCAP Consortium. Lancet Oncology, 2025. e-Pub 2025. PMID: 40112848.
- Attar-Olyaee R, Kouzy R, Rooney MK, Hassanzadeh CJ, Hoffman K, Li JJ, Mohamad O. Cancer Risk Concerns and Communication Gaps Regarding GLP-1 Medications. JAMA Network Open, 2025. e-Pub 2025. PMID: 40679829.
- Mohamad, O, Kouzi, ZE, Kouzy, R, Choi, S, Mok, H, Hoffman, K, Nguyen, Q, Hassanzadeh, CJ, Tang, C, Park, RJ, Shah, SJ, McGuire, SE, Mayo, LL, Kim, Y, Prajapati, S, Vijayan, S, Kudchadker, RJ, Bruno, TL, Frank, SJ. Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer. Brachytherapy 24(2):1-9, 2025. e-Pub 2025. PMID: 40024668.
- Hassanzadeh, CJ, Kuban, DA, Pasyar, S, Bassett Jr, R, Troncoso, P, Ansari, M, Schlembach, PJ, McGuire, SE, Nguyen, Q, Frank, SJ, Mok, H, Mohamad, O, Park, RJ, Tang, C, Du, W, Kudchadker, RJ, Choi, S, Hoffman, K. Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer. Journal of Clinical Oncology 43(18):2044-2048, 2025. e-Pub 2025. PMID: 40367400.
- Hassanzadeh C, Kuban D, Pasyar S, Bassett R, Troncoso P, Maheen, Ansari, Schlembach P, McGuire S, Nguyen Q, Frank S, Mok H, Mohamad O, Park R, Tang C, Wei, Kudchadker R, Choi S, Hoffman K. Hypofractionated, Dose-Escalated Radiation vs Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial. Journal of Clinical Oncology, 2025. e-Pub 2025.
- Mohamad O, Kouzi ZE, Kouzy R, Choi S, Mok H, Hoffman K, Nguyen Q, Hassanzadeh CJ, Tang C, Park RJ, Shah SJ, McGuire SE, Mayo LL, Kim Y, Prajapati S, Vijayan S, Kudchadker RJ, Bruno TL, Frank SJ. Safety and Early Outcomes of Proton Therapy and Low-Dose Rate Brachytherapy Boost for Patients with Prostate Cancer. Brachytherapy, 2025. e-Pub 2025. PMID: 40024668.
- Hassanzadeh C, Mohamad O, Bruno T, Wang L, Kudchakar R, Bathala T, Sanders J, Mok H, McGuire S, Kuban D, Hoffman K, Nguyen Q, Park R, Thames H, Corn P, Chapin B, Choi S, Tang C, Frank S. Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible post-surgical bed recurrences and focal intraprostatic recurrences. Brachytherapy, 2024. e-Pub 2024.
- Thomas H, Chen JJ, Shaheen H, Sabbagh A, Abdul-Baki H, Chau OW, Malik N, Ayoub L, Hassanzadeh C, Hsu I, Mohamad O. Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series. Journal of Contemporary Brachytherapy, 2024. e-Pub 2024. PMID: 38584887.
- Carriere P, Alhalabi O, Gao J, Mohamad O, Campbell MT, Shah A, Goswami S, Bree K, Lee B, Navai N, Mok H, Mayo L, Guo C, Nguyen Q, McGuire S, Park R, Shah S, Hoffman K, Frank S, Tang C, Choi S, Kamat A, Hassanzadeh C. Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. Clinical and Translational Radiation Oncology, 2024. e-Pub 2024. PMID: 39403573.
- Zhao, Y, Cozma, A, Ding, Y, Perles, LA, Reiazi, R, Chen, X, Kang, AM, Prajapati, S, Yu, H, Subashi, ED, Brock, K, Wang, J, Beddar, S, Lee, B, Mohammedsaid, M, Cooper, S, Westley, RL, Tree, A, Mohamad, O, Hassanzadeh, CJ, Mok, H, Choi, S, Tang, C, Yang, J. Upper Urinary Tract Stereotactic Body Radiotherapy Using a 1.5 Tesla Magnetic Resonance Imaging-Guided Linear Accelerator. Cancers 16(23), 2024. e-Pub 2024. PMID: 39682173.
- Thomas H, Chen JJ, Abdul-Baki H, Sabbagh A, Shaheen H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu I, Mohamad O. Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series. Brachytherapy 23(2):173-178, 2023. e-Pub 2023. PMID: 38160102.
- Hassanzadeh C, Mirza K, Kalaghci B, Fallahian F, Chin RI, Roy A, Stowe H, Low G, Pedersen K, Wise P, Glasgow S, Roach M, Henke L, Badiyan S, Mutch M, Kim H. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short Course Radiation for Locally Advanced Rectal Cancer. Dis Colon Rectum 67(1):54-61, 2023. e-Pub 2023. PMID: 37787502.
- Razavian NB, Schutz AN, Chang L, Benitez CM, Sandoval ML, Sharifzadeh Y, Sherer MV, Merfeld EC, Washington C, McKenzie GW, Khan Q, Hassanzadeh CJ, Arbab M. Evaluating the Utility of Webinars on the Radiation Oncology Residency Application Process in the COVID-19 Era. Applied Radiation Oncology, 2023. e-Pub 2023.
- Xu, L, Pacia, CP, Gong, Y, Hu, Z, Chien, CY, Yang, L, Gach, HM, Hao, Y, Hassanzadeh, CJ, Huang, J, Leuthardt, EC, Chen, H. Characterization of the Targeting Accuracy of a Neuronavigation-Guided Transcranial FUS System In Vitro, In Vivo, and In Silico. IEEE Transactions on Biomedical Engineering 70(5):1528-1538, 2023. e-Pub 2023. PMID: 36374883.
- Arbab M, Chaurasia A, Merfeld E, Hassanzadeh C, Sherer M, Razavian N, Schutz A, Sandoval M, Holmes J, Puckett L, Dragun J, Schuster J. Formalized Mentorship in Radiation Oncology in the COVID Era: American College of Radiation Oncology Experience. Applied Radiation Oncology 10(12):18-24, 2021. e-Pub 2021.
- Hassanzadeh C, Rudra S, Ma S, Brenneman R, Huang Y, Henke L, Abraham C, Campian J, Tsien C, Huang J. Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning. Radiother Oncol 158:237-243, 2021. e-Pub 2021. PMID: 33587967.
- Magudia K, Ng TSC, Campbell SR, Balthazar P, Dibble EH, Hassanzadeh CJ, Lall N, Merfeld EC, Esfahani SA, Jimenez RB, Fields EC, Lightfoote JB, Ackerman SJ, Jeans EB, Englander MJ, DeBenedectis CM, Porter KK, Spalluto LB, Deitte LA, Jagsi R, Arleo EK. Family and Medical Leave for Diagnostic Radiology, Interventional Radiology, and Radiation Oncology Residents in the United States: A Policy Opportunity. Radiology 300(1):31-35, 2021. e-Pub 2021. PMID: 33847521.
- Hassanzadeh C, Rudra S, Bommireddy A, Hawkins WG, Wang-Gillam A, Fields RC, Cai B, Park J, Green O, Roach M, Henke L, Kim H. Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Adv Radiat Oncol 6(1):100506, 2021. e-Pub 2021. PMID: 33665480.
- Hassanzadeh C, Roach M, Rich K, Karraker P, Robinson C, Michalski J, Perkins S, Huang J, Tsien C, Abraham C. Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model Policy. Pract Radiat Oncol 10(4):e250-e254, 2020. e-Pub 2020. PMID: 32004704.
- Hassanzadeh C, Sita T, Savoor R, Samson PP, Bradley J, Gentile M, Roach M, Mohindra N, Waqar S, Kruser TJ, Robinson C. Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer. J Thorac Dis 12(11):6690-6700, 2020. e-Pub 2020. PMID: 33282370.
- Lin AJ, Hassanzadeh C, Markovina S, Schwarz J, Grigsby P. Brachytherapy and survival in small cell cancer of the cervix and uterus. Brachytherapy 18(2):163-170, 2019. e-Pub 2019. PMID: 30563743.
- Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, Dunlap NE, Zakem SJ, Hassanzadeh C, Marcrom S, Boggs DH, Isrow D, Vargo JA, Heron DE, Siddiqui F, Bonner JA, Beitler JJ, Yao M, Trotti AM, Riaz N, (MIRI) Collaborative MR. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Oral Oncol 90:80-86, 2019. e-Pub 2019. PMID: 30846182.
- Brenneman RJ, Sharifai N, Fischer-Valuck B, Hassanzadeh C, Guzelian J, Chrisinger JSA, Michalski JM, Oppelt P, Baumann BC. Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma. Front Oncol 9(SEP):922, 2019. e-Pub 2019. PMID: 31616634.
- Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Marcrom S, Boggs DH, Hassanzadeh C, Reddy CA, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, (MIRI) Collaborative MR. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. Int J Radiat Oncol Biol Phys 100(3):586-594, 2018. e-Pub 2018. PMID: 28865925.
- Caudell JJ, Ward MC, Riaz N, Zakem SJ, Awan MJ, Dunlap NE, Isrow D, Hassanzadeh C, Vargo JA, Heron DE, Marcrom S, Boggs DH, Reddy CA, Dault J, Bonner JA, Higgins KA, Beitler JJ, Koyfman SA, Machtay M, Yao M, Trotti AM, Siddiqui F, Lee NY, (MIRI) Collaborative MR. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. Int J Radiat Oncol Biol Phys 100(3):606-617, 2018. e-Pub 2018. PMID: 29413274.
- Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Hassanadeh C, Beitler JJ, Reddy CA, Marcrom S, Boggs DH, Bonner JA, Yao M, Machtay M, Siddiqui F, Y Lee AMT, Koyfman SA, Ferris RL, Heron DE. A Multi-Institution Comparison of SBRT and IMRT for Definitive Re-Irradiation of Recurrent or Second Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys 100(3), 2018. e-Pub 2018. PMID: 28899556.
- Rao YJ, Chundury A, Schwarz JK, Hassanzadeh C, DeWees T, Mullen D, Powell MA, Mutch DG, Grigsby PW. Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes. Adv Radiat Oncol 2(2):148-158, 2017. e-Pub 2017. PMID: 28740926.
- Rao YJ, Hassanzadeh C, Fischer-Valuck B, Chicoine MR, Kim AH, Perkins SM, Huang J. Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database. J Neurooncol 132(1):109-117, 2017. e-Pub 2017. PMID: 28012064.
- Rao YJ, Hassanzadeh C, Chundury A, Hui C, Siegel BA, Dehdashti F, DeWees T, Mullen D, Powell MA, Mutch DG, Schwarz JK, Grigsby PW. Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva. Radiother Oncol 122(3):445-451, 2017. e-Pub 2017. PMID: 28063696.
- Hassanzadeh C, Rao YJ, Chundury A, Rowe J, Ponisio MR, Sharma A, Miller-Thomas M, Tsien CI, Ippolito JE. Multiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. Front Oncol 7(AUG):178, 2017. e-Pub 2017. PMID: 28868256.
- Song N, Guan R, Jiang Q, Hassanzadeh CJ, Chu Y, Zhao X, Wang X, Yang D, Du Q, Chu XP, Shen L. Acid-sensing ion channels are expressed in the ventrolateral medulla and contribute to central chemoreception. Sci Rep 6:38777, 2016. e-Pub 2016. PMID: 27934921.
Review Articles
- Gupta S, Hensley PJ, Li R, Choudhury A, Daneshmand S, Faltas BM, Flaig TW, Grass G, Grivas P, Hansel DE, Hassanzadeh C, Kassouf W, Kukreja J, Mendoza-Valdés A, Moschini M, Mouw KW, Navai N, Necchi A, Rosenberg JE, Ross t JS, Siefker-Radtke AO, Taylor J, Willliams SB, Zlotta y AR, Buckley R, Kamat AM. Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group. European Urology, 2025. e-Pub 2025. PMID: 40268594.
Other Articles
- Kouzy R, Attar-Olyaee R, Rooney MK, Hassanzadeh CJ, Li JJ, Mohamad O QuaLLM-Health: An Adaptation of an LLM-Based Framework for Quantitative Data Extraction from Online Health Discussions. ArXiv Labs: Experimental Projecs with Community Collaborators, 2024.
Abstracts
- Nalin A, Hoffman K, Campbell M, Lin J, Shah A, Johns A, Prajapati S, Lozano C, Ward J, Park R, Tang C, Mok H, Mohamad O, Choi S, Hassanzadeh C. Outcomes of Stage IIA and Stage IIB Seminoma Treated with Definitive Radiation Therapy. ASTRO 2025, 2025. e-Pub 2025.
- Carriere P, Alhalabi O, Gao J, Shah A, Goswami S, Campbell M, Lin R, Mayo L, Mohamad O, Hoffman K, Mok H, Lozano C, Kamat A, Navai N, Bree K, Lee B, Guo C, Tang C, Choi S, Hassanzadeh C. Metastasis-directed radiotherapy in oligometastatic bladder and upper tract cancer: A single institution retrospective experience. ASCO GU Symposium 2025, 2025. e-Pub 2025.
- Patel P, Shah S, Mohamad O, Mok H, Choi S, Hoffman K, Tang C, Mayo L, Park R, McGuire S, Nguyen Q, Frank S, Chapin B, Graber W, Hassanzadeh C. Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer Following Transurethral Resection of Prostate or Laser Enucleantion. ASTRO 2025, 2025. e-Pub 2025.
- Ansari M, Hoffman K, Mok H, Frank S, Nguyen Q, Tang C, McGuire S, Mayo L, Shah S, Prajapati S, Surasi DS, Pilie P, Lozano C, Mohamad O, Choi S, Hassanzadeh C. Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy. ASTRO 2025, 2025. e-Pub 2025.
- McCullum L, Yang J, Ding Y, Choi S, Hassanzadeh C, Koay E, Mohamad O, Tang C, Fuller C, Balter P, Wang J, Subashi E. Longitudinal Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac. ASTRO 2025, 2025. e-Pub 2025.
- Mohamad O, Kouzi ZE, Choi S, Mok H, Hoffman K, Nguyen Q, Hassanzadeh CJ, Tang C, Shah SJ, McGuire SE, Mayo LL, Kim Y, Prajapati S, Vijayan S, Kudchadker RJ, Bruno TL, Kouzy R, Frank SJ. Safety and Early Outcomes of External Beam Radiation Therapy with Low-Dose Brachytherapy Boost in Patients with Prostate Cancer. ASTRO 2025, 2025. e-Pub 2025.
- Zhao Y, Yang J, Perles L, Reiazi R, Chen X, Prajapati S, Subashi E, Yu H, Brock K, Wang J, Mohamad O, Hassanzadeh C, Choi S, Tang C, Ding Y. Respiratory Motion Management using Compression Belt for MR-guided Stereotactic Body Radiotherapy of Kidney Cancer. American Association of Physicists in Medicine 2024, 2024. e-Pub 2024.
- Hassanzadeh C. Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience. ASTRO 2024, 2024. e-Pub 2024.
- Hassanzadeh, Alhalabi, Kamat, Gao, Lee, Tang, Mayo, Guo, Campbell, Shah, Nguyen, Shah, Mohamad, Park, Kuban, Goswami, Mok, Hoffman, Navai, Choi. Outcomes After Radiotherapy for Locally Advanced and Node Positive Muscle Invasive Bladder Cancer. European Society of Therapeutic Radiation Oncology 2024 Annual Conference, 2024. e-Pub 2024.
- Hassanzadeh C. Stereotactic Body Radiotherapy for Prostate Cancer with Magnetic Resonance Imaging or Computed Tomography Guidance. ASTRO 2024, 2024. e-Pub 2024.
- Carriere, Alhalabi, Gao, Campbell, Kamat, Navai, Lee, Bree, Tang, Hoffman, Choi, Mohamad, Mok, Mayo, Hassanzadeh. Evaluating the efficacy of radiation therapy in MTAP-deficient bladder cancer. American Radium Society 2024 Annual Meeting, 2024. e-Pub 2024.
- Hassanzadeh C. Post Pelvic Radiotherapy Non Muscle Invasive Bladder Cancer Recurrence with BCG Salvage. American Urological Association 2024, 2024. e-Pub 2024.
- Chang E, Hassanzadeh C, Mohamad O, Choi S, Tang C, Nguyen Q. Stereotactic Body Radiotherapy for Prostate Cancer with Magnetic Resonance Imaging or Computed Tomography Guidance. American Society of Therapeutic Radiation Oncology 2024, 2024. e-Pub 2024.
- Mohamad O, Hassanzadeh C, Mok H, Tang C, Frank S. Proton Therapy with Brachytherapy Boost in Patients with Prostate Cancer: the MD Anderson Cancer Center Experience. American Brachytherapy Society 2024, 2024. e-Pub 2024.
- Liu W, Schiff JP, Hassanzadeh C, Miller K, Hatscher C, Beckert R, Daly M, Brenneman R, Apicelli A, Moravan M, Thorstad W, Laugeman E. Palliative Expeditiously Adaptive Quad Shot Radiotherapy for Head and Neck Cancers (PEAQ-RT). European Society of Therapeutic Radiation Oncology 2024, 2024. e-Pub 2024.
- Su, L, Pacia, C, Gong, Y, Chien, C-Y, Hu, Z, Yang, L, Gach, M, Hao, Y, Hassanzadeh, C, Huang, J, Leuthardt, E, Chen, H. Development of a neuronavigation-guided sonobiopsy device for glioblastoma patients. IEEE International Ultrasonics Symposium, 2022. e-Pub 2022.
- Arbab, M, Chaurasia, A, Hassanzadeh, C, Feng, C, Merfeld, E, Sherer, M, Fernandez, C, Everett, A, Schuster, J. Mentor/Mentee is How to Succeed – Summary of ACRO Mentorship Program 2020-21. American College of Radiation Oncology (ACRO) 2021 Annual Meeting, 2021. e-Pub 2021.
- Hassanzadeh, C, Fallahian, F, Low, G, Roy, A, Chin, R, Pedersen, K, Mutch, M, Glasgow, S, Henke, L, Badiyan, S, Kim, H. Lateral Pelvic Nodal Boost During Short Course Radiation Therapy for Locally Advanced Rectal Cancer. European Society of Radiation Oncology (ESTRO) 2021 Annual Meeting, 2021. e-Pub 2021.
- Arbab, M, Chaurasia, A, Merfeld, E, Hassanzadeh, C, Feng, C, Sherer, M, Fernandez, C, Everett, A, Holmes, J, Puckett, L, Schuster, J. Formalized Mentorship in Radiation Oncology: Bridging Existing Gaps in Mentorship. ASTRO 2021 Annual Meeting, 2021. e-Pub 2021.
- Laugeman, E, Hassanzadeh, C, Pryser, E, Hugo, G, Mutic, S, Henke, L Thorstad L, W, Cai, B, Daly, M. Head and Neck Quad Shot Using CT Based Adaptive Treatment on a Ring Gantry LINAC. ASTRO 2020 Annual Meeting, 2020. e-Pub 2020.
- Hassanzadeh, C, Rudra, S, Ma, S, Abraham, C, Campian, J, Huang, J. Early MRI Changes of Glioblastoma During Chemoradiotherapy and Implications for Treatment Planning. ASTRO 2020 Annual Meeting, 2020. e-Pub 2020.
- Hassanzadeh, C, Rudra, S, Bommireddy, A, Hawkins, W, Wang-Gillam, A, Fields, R, Cai, B, Park, J, Green, O, Roach, M, Henke, L, Kim, H. Stereotactic MR-Guided Adaptive Radiation Therapy for Inoperable Pancreatic Cancer Using a 5- Fraction Approach. European Society of Radiation Oncology (ESTRO) 2020 Annual Meeting, 2020. e-Pub 2020.
- Hassanzadeh, C, Srivastava, A, Markovina, S, Schwarz, J, Grigsby, P. Prognostic significance of p16 in patients with cervical cancer receiving chemoradiation. American Radium Society (ARS) 2019 Annual Meeting, 2019. e-Pub 2019.
- Sita, T, Hassanzadeh, C, Savoor, R, Samson, P, Bradley, J, Gentile, M, Roach, M, Mohindra, N, Waqar, S, Robinson, C, Kruser, T. Multi-institutional Study of Pneumonitis after Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer. IASLC 2019 Annual Meeting, 2019. e-Pub 2019.
- Ward, M, Caudell, J, Dunlap, N, Hassanzadeh, C, Reddy, C, Bonner, J, Koyfman, S, Riaz, N. A Competing Risk Nomogram to Predict Severe Late Toxicity After Modern Re-Irradiation for Squamous Carcinoma of the Head and Neck. ASTRO 2017 Annual Meeting, 2017. e-Pub 2017.
- Hassanzadeh, C, Rao, Y, Schwarz, J, DeWees, T, Siegel, B, Dehdashti, F, Grigsby, P. Correlation & Prognostic Significance of Pre-Treatment F-FDG- and Cu-ATSM-PET/CT for Cervical Cancer. ASTRO 2017 Annual Meeting, 2017. e-Pub 2017.
- Hassanzadeh, C, Chundury, A, Rowe, J, Miller-Thomas, M, Tsien, C. A Single Institution Experience with the Utility of Brain Simultaneous 18F-FDG-PET/MRI to Differentiate Tumor Recurrence from Radiation Necrosis. Int J Radiat Oncol Biol Phys, 2017. e-Pub 2017.
- Ippolito, J, Colen, R, Hassanzadeh, C, Rao, Y (James) Y, Ponisio, M, Tsien, C, Chinnaiyan, P, Rubin, J. Identification of a Clinically-Actionable Sexual Dimorphism in Glioblastoma Glycolysis. Society of Neuro-oncology 2017 Annual Meeting, 2017. e-Pub 2017.
- Rao, Y (James) Y, Hassanzadeh, C, Chundury, A, Rowe, J, Ponisio, M, Sharma, A, Miller-Thomas, M, Tsien, C, Ippolito, J. Multiparametric Advanced MR and FDG PET Imaging is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. ASTRO 2017 Annual Meeting, 2017. e-Pub 2017.
- Ward, M, Riaz, N, Caudell, J, Dunlap, N, Hassanzadeh, C, Reddy, C, Bonner, J, Koyfman, S. Refining Patient Selection for Re-Irradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-Institution Cohort Study by the MIRI Collaborative. ASTRO 2016 Annual Meeting, 2016. e-Pub 2016.
- Hassanzadeh, C, Jiang, Q, Sharma, A, Chu, X. Regulation of Locomotor Activity following Amphetamine Administration by Acid-sensing Ion Channel in Adult Mice. Journal of Academic Medicine, 2016. e-Pub 2016.
- Hassanzadeh, C, Rao, Y (James) Y, Schwarz, J, Dewees, T, Mullen, D, Powell, M, Mutch, D, Grigsby, P. Association of Post- Treatment Positron Emission Tomography Response with Local-regional Control and Survival after Radiation for Vulvar Cancer. RSNA 2016 Annual Meeting, 2016. e-Pub 2016.
- Jiang, Q, Song, N, Guan, R, Hassanzadeh, C, Chu, Y, Wang, X, Shen, L, Chu, X. Acid-Sensing Ion Channels in Ventrolateral Medulla Contribute to Central Chemoreception. Society of Neuroscience 2016 Annual Meeting, 2016. e-Pub 2016.
- Presker, M, Albers, JA, Varade, N, Hassanzadeh, C, Anch, M. Adenosinergic Modulation of Spatial Memory and Motor Function in Parkinson’s disease. Saint Louis Research Symposium, 2011. e-Pub 2011.
- Shin K, Choi S, Nguyen Q, Tang C, Hoffman KE, Hassanzadeh C, Mohamad O, Park RJ, Corn PG, Mcguire SE, Mok H, Ward JF, Buszek SM, Antonoff M. External beam radiation therapy for salvage after focal therapy as primary treatment in prostate adenocarcinoma. 2025 ASCO Annual Meeting.
Web Publications
- Carriere P, Alhalabi O, Gao J, Mohamad O, Campbell MT, Shah A, Goswami S, Bree K, Lee B, Navai N, Mok H, Mayo L, Guo C, Nguyen Q, McGuire S, Park R, Shah S, Hoffman K, Frank S, Tang C, Choi S, Kamat A, Hassanzadeh C. Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer, 2024.
Patient Reviews
CV information above last modified August 20, 2025